Today: 19 May 2026
Browse Category

NYSE:CL 28 October 2025 - 2 May 2026

S&P 500 And Nasdaq Hit Records As Apple Rally Defies Oil Shock — For Now

S&P 500 And Nasdaq Hit Records As Apple Rally Defies Oil Shock — For Now

The S&P 500 and Nasdaq closed at record highs Friday, with the S&P 500 up 0.29% and the Nasdaq rising 0.89%, boosted by strong Apple earnings. The Dow fell 0.31%. Oil prices eased but remained above $100 a barrel, while Treasury yields stayed elevated. High-yield credit spreads neared multi-year lows as investors continued to buy risk assets despite ongoing tensions with Iran.
2 May 2026
·········
Colgate-Palmolive Stock Rises After Earnings Beat. A $300 Million Cost Hit Still Looms

Colgate-Palmolive Stock Rises After Earnings Beat. A $300 Million Cost Hit Still Looms

Colgate-Palmolive beat first-quarter sales and profit estimates, driven by international growth, while North America volumes fell 3.2%. The company warned of about $300 million in extra raw-material and logistics costs this year due to Middle East conflict. Net sales rose 8.4% to $5.32 billion; shares climbed 3.1%. Colgate lowered its gross profit margin outlook and expanded its cost-cutting program.
1 May 2026
··
Procter & Gamble stock price ends Friday higher as tariff ruling sets up the week for PG shares

Procter & Gamble stock price ends Friday higher as tariff ruling sets up the week for PG shares

Procter & Gamble shares closed up 1.4% at $160.78 on Friday, outpacing both the S&P 500 and the consumer-staples sector. The move followed a Supreme Court ruling striking down Trump-era tariffs and new data showing U.S. GDP growth at 1.4% with core inflation at 2.7%. Investors have rotated into staples amid policy shifts and economic uncertainty. P&G last reported quarterly sales up 1% to $22.21 billion.
22 February 2026
····
P&G stock slides while Wall Street rises — what investors are watching this week

P&G stock slides while Wall Street rises — what investors are watching this week

Procter & Gamble shares fell 1.2% to $157.24 in Monday afternoon trading, underperforming the broader market as consumer-staples stocks weakened. Investors are awaiting U.S. jobs and inflation data due later this week. P&G’s last update showed flat sales and profit, with volume declines in key segments. The company declared a quarterly dividend of $1.0568 per share, payable Feb. 17.
9 February 2026
···
P&G stock price climbs in late trade as investors rotate to defensives — and an insider sale hits the tape

P&G stock price climbs in late trade as investors rotate to defensives — and an insider sale hits the tape

Procter & Gamble shares rose 1.1% to $158.61 in after-hours trading, outperforming broader market declines. CEO Ma. Fatima D. Francisco sold 8,000 shares at $158 each on Feb. 4, according to a regulatory filing. U.S. jobless claims increased to 231,000, while job openings fell to 6.542 million. P&G’s Gillette Venus announced a partnership with U.S. Figure Skating ahead of the Milano Cortina Winter Games.
6 February 2026
···
Colgate stock pops after hours as Wall Street lifts targets — what’s next for NYSE:CL

Colgate stock pops after hours as Wall Street lifts targets — what’s next for NYSE:CL

Colgate-Palmolive shares rose 1.8% to $91.89 in after-hours trading Monday after brokerages raised price targets following the company’s quarterly update and 2026 outlook. The company projected 2026 net sales growth of 2% to 6%, with price hikes adding 2.7% to recent results while volumes stayed flat. Colgate booked a $794 million non-cash charge tied to its skin health business.
2 February 2026
·
Colgate-Palmolive (CL) stock price jumps nearly 6% after outlook — what to watch before Monday

Colgate-Palmolive (CL) stock price jumps nearly 6% after outlook — what to watch before Monday

Colgate-Palmolive shares jumped 5.9% to $90.29 Friday after quarterly earnings beat estimates and the company raised its 2026 sales forecast. The company posted a GAAP loss due to a $794 million impairment charge but reported adjusted earnings per share of 95 cents on $5.23 billion in sales. U.S. markets reopen Monday. CEO Noel Wallace cited ongoing challenges from weak category growth and higher costs.
1 February 2026
··
Colgate-Palmolive stock price jumps 6% after earnings; what CL investors watch next week

Colgate-Palmolive stock price jumps 6% after earnings; what CL investors watch next week

Colgate-Palmolive shares rose 6% to $90.29 Friday after fourth-quarter net sales climbed 5.8% to $5.23 billion, but GAAP earnings swung to a loss due to a $794 million skin-health impairment. The company’s 2026 outlook includes finalized tariffs and projects net sales growth of 2% to 6%. North America sales fell, while Latin America and Africa/Eurasia posted double-digit gains.
31 January 2026
··
Colgate-Palmolive stock price jumps 5% after earnings beat and upbeat 2026 sales forecast

Colgate-Palmolive stock price jumps 5% after earnings beat and upbeat 2026 sales forecast

Colgate-Palmolive shares rose 5.2% to $89.70 Friday after the company beat Q4 profit forecasts and projected 2026 net sales growth of 2% to 6%. A $794 million after-tax impairment charge pushed GAAP results to a quarterly loss. Q4 net sales reached $5.23 billion, with adjusted earnings of 95 cents per share. Demand held steady in Latin America and Europe, while North American volumes stayed flat.
30 January 2026
···
Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next

Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next

Procter & Gamble shares rose 1.1% to $151.58 Friday afternoon as investors moved into consumer-staples stocks amid inflation concerns and policy uncertainty. The S&P 500 fell 0.4% while the XLP staples ETF gained 1.2%. Senate obstacles raised the risk of a partial U.S. government shutdown before the midnight funding deadline. Investors await the Feb. 6 jobs report and further policy signals.
30 January 2026
····
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 28.10.2025

Colgate-Palmolive shares fell 3% in the past month, with a 1-year total return of -16.6% despite steady earnings. Agilysys and Wayfair hit 52-week highs after beating estimates and raising guidance. U.S. stocks closed near records Oct. 28; ReNew Energy Global surged 241% while Co-Diagnostics plunged 55%. American Bitcoin (ABTC) dropped 5% during a volatile week.
28 October 2025
····

Stock Market Today

  • LeMaitre Q1 Performance Trails Surgical Equipment Sector Leaders
    May 19, 2026, 5:33 AM EDT. LeMaitre (NASDAQ:LMAT) reported Q1 revenue of $66.55 million, up 11.2% year-on-year but missed the mark relative to analyst estimates and offered weaker full-year guidance than peers. Despite beating earnings per share (EPS) estimates for the upcoming quarter, LMAT's stock fell 10%, trading at $100.83. In contrast, sector leader Intuitive Surgical (NASDAQ:ISRG) delivered a 23% revenue increase to $2.77 billion, surpassing expectations by 5.8%, driven by its robotic-assisted surgical systems business. The surgical equipment and consumables sector as a whole beat revenue estimates by 2.7% for Q1, with stocks rising an average of 6.4%. Industry growth is underpinned by aging populations and expanding use of AI and robotics, although challenges remain around R&D costs, regulatory compliance, pricing pressures, and potential supply chain issues.

Latest articles

Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

19 May 2026
Alphabet shares rose in pre-market trading Tuesday after Google and Blackstone announced a U.S. AI cloud venture, with Blackstone committing $5 billion to add 500 megawatts of data-center capacity by 2027. Alphabet’s Class A shares closed Monday at $396.94 and were quoted at $401.09 before the market opened. The move coincides with the first day of Google I/O and follows strong Q1 earnings.
GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

19 May 2026
GeoVax Labs shares surged nearly 80% to $2.21 Monday after announcing a $3 million private placement amid heightened interest in biodefense following a WHO emergency alert over Ebola in Africa. The company does not sell an approved Ebola vaccine; its lead candidate targets mpox and smallpox. GeoVax reported $1.3 million in cash at March 31 and a quarterly net loss of $5.3 million. The new funding is expected to close around May 19.
Evolution stock jumps on €2 billion move

Evolution stock jumps on €2 billion move

19 May 2026
Evolution AB shares surged 9% in Stockholm after the company announced a €2 billion share buyback, one of Sweden’s largest. The buyback starts immediately and may run until the 2027 annual meeting, capped at 10% of shares. The OMXS30 index rose just 0.75% in comparison. Evolution also secured a €300 million revolving credit facility from J.P. Morgan SE and Citibank Europe.

Popular

Zeta Global Surges 12% After OpenAI Ad Remarks

Zeta Global Surges 12% After OpenAI Ad Remarks

19 May 2026
Zeta Global shares rose 11.6% to $19.19 Monday after CEO David Steinberg said the company reached an agreement to help OpenAI run its advertising. The stock outperformed the broader market, with SPY and QQQ both down. Zeta recently joined Snowflake’s Open Semantic Interchange and reported Q1 revenue up 50% year-over-year. Investors cited strong guidance and increased Athena AI agent usage.
Go toTop